A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa

Reintubation and subsequent mechanical ventilation (MV) in preterm infants after surfactant replacement therapy are associated with excess morbidity and mortality and likely increase in-hospital costs. Specific surfactant therapy selection for prevention of respiratory distress syndrome (RDS) in pre...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of pediatric pharmacology and therapeutics 2012-07, Vol.17 (3), p.220-227
Hauptverfasser:	Guardia, Carlos G, Moya, Fernando R, Sinha, Sunil, Simmons, Phillip D, Segal, Robert, Greenspan, Jay S
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Investigation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!